SCHEMBL9906320

SCHEMBL9906320

O=C(CCSCc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1)ON1C(=O)CCC1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ ESR1 P03372 1/20 0.48
▸ CA9 Q16790 14/20 0.47
▸ CA1 P00915 12/20 0.47
▸ CA2 P00918 12/20 0.47
▸ CA12 O43570 4/20 0.47
▸ CA14 Q9ULX7 3/20 0.47
▸ MEN1 O00255 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ALPL P05186 1/20 0.46
▸ ALPI P09923 1/20 0.46
▸ ALPG P10696 1/20 0.46
▸ CA7 P43166 3/20 0.45
▸ ATM Q13315 1/20 0.44
▸ PLEC Q15149 1/20 0.44
▸ DNASE1L3 Q13609 1/20 0.42
▸ PRMT1 Q99873 1/20 0.42
▸ ALB P02768 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23808967 0.89 USP2 (0.60) USP2L3MBTL1ESR1CA9CA1
SCHEMBL14619874 0.86 USP2 (0.63) USP2L3MBTL1ESR1CA9CA1
SCHEMBL1688096 0.86 CA9 (0.52) USP2L3MBTL1CA9CA1CA2
SCHEMBL29837449 0.86 CA9 (0.52) USP2L3MBTL1CA9CA1CA2
SCHEMBL13678665 0.84 ESR1 (0.52) USP2L3MBTL1ESR1CA9CA1
SCHEMBL19451947 0.84 USP2 (0.62) USP2L3MBTL1ESR1CA9CA1
SCHEMBL9906193 0.83 CA9 (0.49) USP2L3MBTL1CA9CA1CA2
SCHEMBL1688099 0.83 FOLH1 (0.51) USP2L3MBTL1ESR1CA9CA1
SCHEMBL20821271 0.83 USP2 (0.55) USP2L3MBTL1ESR1CA9CA1
SCHEMBL9906260 0.82 DNASE1L3 (0.51) USP2L3MBTL1CA9CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673399-B1 DETECTING AND PROFILING MOLECULAR COMPLEXES MONOGRAM BIOSCIENCES INC (US) 2017-04-05 — — EP disclosed
US-8198031-B2 Using epidermal growth factor receptor complexes to diagnose and prognose health in cancer patients; drug screening MONOGRAM BIOSCIENCES, INC. (US) 2012-06-12 — — US disclosed
US-20090011432-A1 Detecting and Profiling Molecular Complexes MONOGRAM BIOSCIENCES, INC. (US) 2009-01-08 — — US disclosed
US-20080233602-A1 Detecting and profiling molecular complexes MONOGRAM BIOSCIENCES, INC. 2008-09-25 — — US disclosed
US-7402397-B2 Detecting and profiling molecular complexes MONOGRAM BIOSCIENCES, INC. (US) 2008-07-22 — — US disclosed
US-7255999-B2 Detection of preferential polypetide in sample; otain sample containing preferential polyeptide, electrophorese, incubate with probe, detect signal from probe and recover polypeptide MONOGRAM BIOSCIENCES, INC. (US) 2007-08-14 — — US disclosed
US-7217531-B2 Multiplex analysis using membrane-bound sensitizers MONOGRAM BIOSCIENCES (US) 2007-05-15 — — US disclosed
US-7160735-B2 Tagged microparticle compositions and methods MONOGRAM BIOSCIENCES, INC. (US) 2007-01-09 — — US disclosed
Send feedback